European Industry Urges Action On Unequal Access To Biosimilars
Cites ‘Inequity Across EU Member States’ As A ‘Major Concern’ To Address At All Levels
Medicines for Europe called for both EU and national-level measures to address inequalities • Source: Shutterstock 
